Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

ClinicalTrials.gov ID: NCT04989283

Public ClinicalTrials.gov record NCT04989283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

NASSIST (Neoadjuvant Chemoradiation +/- Immunotherapy Before Surgery for Superior Sulcus Tumors): A Randomized Phase II Trial of Trimodality +/- Atezolizumab in Resectable Superior Sulcus Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial tests the effect of atezolizumab given with usual chemotherapy during radiation therapy in treating patients with superior sulcus non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, carboplatin, etoposide, paclitaxel and pemetrexed, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Giving atezolizumab with usual chemotherapy and radiation therapy may lower the chance of the tumor from growing or spreading.

Study identification

NCT ID
NCT04989283
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 9, 2021 (Estimated)
Primary completion
May 10, 2031 (Estimated)
Completion
May 10, 2031 (Estimated)
Last update posted
Sep 26, 2023

2021 – 2031

United States locations

U.S. sites
46
U.S. states
15
U.S. cities
44
Facility City State ZIP Site status
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro Arkansas 72401 —
Moffitt Cancer Center Tampa Florida 33612 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Saint Alphonsus Cancer Care Center-Caldwell Caldwell Idaho 83605 —
Kootenai Health - Coeur d'Alene Coeur d'Alene Idaho 83814 —
Saint Alphonsus Cancer Care Center-Nampa Nampa Idaho 83687 —
Kootenai Clinic Cancer Services - Post Falls Post Falls Idaho 83854 —
Kootenai Cancer Clinic Sandpoint Idaho 83864 —
Rush - Copley Medical Center Aurora Illinois 60504 —
Carle at The Riverfront Danville Illinois 61832 —
Carle Physician Group-Effingham Effingham Illinois 62401 —
Carle Physician Group-Mattoon/Charleston Mattoon Illinois 61938 —
Carle Cancer Center Urbana Illinois 61801 —
Mary Greeley Medical Center Ames Iowa 50010 —
McFarland Clinic - Ames Ames Iowa 50010 —
McFarland Clinic - Boone Boone Iowa 50036 —
McFarland Clinic - Trinity Cancer Center Fort Dodge Iowa 50501 —
McFarland Clinic - Jefferson Jefferson Iowa 50129 —
McFarland Clinic - Marshalltown Marshalltown Iowa 50158 —
Baptist Memorial Hospital and Cancer Center-Golden Triangle Columbus Mississippi 39705 —
Baptist Cancer Center-Grenada Grenada Mississippi 38901 —
Baptist Memorial Hospital and Cancer Center-Union County New Albany Mississippi 38652 —
Baptist Memorial Hospital and Cancer Center-Oxford Oxford Mississippi 38655 —
Baptist Memorial Hospital and Cancer Center-Desoto Southhaven Mississippi 38671 —
Billings Clinic Cancer Center Billings Montana 59101 —
Bozeman Deaconess Hospital Bozeman Montana 59715 —
Benefis Healthcare- Sletten Cancer Institute Great Falls Montana 59405 —
Kalispell Regional Medical Center Kalispell Montana 59901 —
Community Medical Hospital Missoula Montana 59804 —
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon New Hampshire 03756 —
Mount Sinai Chelsea New York New York 10011 —
Mount Sinai Hospital New York New York 10029 —
Adena Regional Medical Center Chillicothe Ohio 45601 —
University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio 45219 —
The Mark H Zangmeister Center Columbus Ohio 43219 —
University of Cincinnati Cancer Center-West Chester West Chester Ohio 45069 —
Saint Ann's Hospital Westerville Ohio 43081 —
Genesis Healthcare System Cancer Care Center Zanesville Ohio 43701 —
Cancer Centers of Southwest Oklahoma Research Lawton Oklahoma 73505 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Saint Alphonsus Medical Center-Ontario Ontario Oregon 97914 —
Baptist Memorial Hospital and Cancer Center-Collierville Collierville Tennessee 38017 —
Baptist Memorial Hospital and Cancer Center-Memphis Memphis Tennessee 38120 —
Norris Cotton Cancer Center-North Saint Johnsbury Vermont 05819 —
Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
Marshfield Clinic-Minocqua Center Minocqua Wisconsin 54548 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04989283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 26, 2023 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04989283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →